Fund profile
Fund manager
Total assets
$4.24 mm
Liabilities
$270.90 k
Net assets
$3.97 mm
Number of holdings
139.00
139 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
BlackRock Cash Funds: Treasury, SL Agency Shares | 200.00 k | 200.00 k shares | 5.04 | Short-term investment vehicle | Long | USA |
BSX Boston Scientific Corp. | 137.27 k | 2.17 k shares | 3.46 | Common equity | Long | USA |
BlackRock Cash Funds: Institutional, SL Agency Shares | 132.16 k | 132.08 k shares | 3.33 | Short-term investment vehicle | Long | USA |
COR Cencora Inc. | 129.37 k | 556.00 shares | 3.26 | Common equity | Long | USA |
AMGN AMGEN Inc. | 87.68 k | 279.00 shares | 2.21 | Common equity | Long | USA |
Novo Nordisk A/S
|
81.04 k | 709.00 shares | 2.04 | Common equity | Long | Denmark |
COO Cooper Companies, Inc. | 80.57 k | 216.00 shares | 2.03 | Common equity | Long | USA |
ABBV Abbvie Inc | 80.06 k | 487.00 shares | 2.02 | Common equity | Long | USA |
ISRG Intuitive Surgical Inc | 78.67 k | 208.00 shares | 1.98 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 76.72 k | 287.00 shares | 1.93 | Common equity | Long | USA |
BMRN Biomarin Pharmaceutical Inc. - Registered Shares | 75.13 k | 853.00 shares | 1.89 | Common equity | Long | USA |
ARGX Argen X SE | 71.54 k | 188.00 shares | 1.80 | Common equity | Long | Netherlands |
QIAGEN NV
|
66.45 k | 1.52 k shares | 1.67 | Common equity | Long | Netherlands |
TECH Bio-Techne Corp | 61.18 k | 870.00 shares | 1.54 | Common equity | Long | USA |
DHR Danaher Corp. | 60.94 k | 254.00 shares | 1.54 | Common equity | Long | USA |
UNH Unitedhealth Group Inc | 60.90 k | 119.00 shares | 1.53 | Common equity | Long | USA |
ZBH Zimmer Biomet Holdings Inc | 60.54 k | 482.00 shares | 1.53 | Common equity | Long | USA |
MASI Masimo Corp | 60.34 k | 468.00 shares | 1.52 | Common equity | Long | USA |
WAT Waters Corp. | 60.05 k | 189.00 shares | 1.51 | Common equity | Long | USA |
MTD Mettler-Toledo International, Inc. | 59.86 k | 50.00 shares | 1.51 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 57.82 k | 155.00 shares | 1.46 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 57.73 k | 413.00 shares | 1.45 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 57.46 k | 89.00 shares | 1.45 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 54.64 k | 316.00 shares | 1.38 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 54.38 k | 457.00 shares | 1.37 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 53.05 k | 667.00 shares | 1.34 | Common equity | Long | USA |
MOH Molina Healthcare Inc | 51.68 k | 145.00 shares | 1.30 | Common equity | Long | USA |
MCK Mckesson Corporation | 51.49 k | 103.00 shares | 1.30 | Common equity | Long | USA |
BIIB Biogen Inc | 50.81 k | 206.00 shares | 1.28 | Common equity | Long | USA |
MRK Merck & Co Inc | 50.12 k | 415.00 shares | 1.26 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals Inc. | 46.93 k | 1.06 k shares | 1.18 | Common equity | Long | USA |
Gerresheimer AG
|
46.59 k | 457.00 shares | 1.17 | Common equity | Long | Germany |
Immunocore Holdings PLC
|
46.48 k | 643.00 shares | 1.17 | Common equity | Long | UK |
CRL Charles River Laboratories International Inc. | 45.42 k | 210.00 shares | 1.14 | Common equity | Long | USA |
LEGN Legend Biotech Corp | 44.82 k | 814.00 shares | 1.13 | Common equity | Long | Cayman Islands |
PCVX Vaxcyte Inc | 41.21 k | 577.00 shares | 1.04 | Common equity | Long | USA |
BDX Becton Dickinson & Co. | 41.08 k | 172.00 shares | 1.03 | Common equity | Long | USA |
ELAN Elanco Animal Health Inc | 40.83 k | 2.77 k shares | 1.03 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc | 39.88 k | 882.00 shares | 1.00 | Common equity | Long | Canada |
STERIS PLC
|
38.97 k | 178.00 shares | 0.98 | Common equity | Long | Ireland |
CTLT Catalent Inc. | 38.06 k | 737.00 shares | 0.96 | Common equity | Long | USA |
INSP Inspire Medical Systems Inc | 37.75 k | 179.00 shares | 0.95 | Common equity | Long | USA |
RGEN Repligen Corp. | 37.12 k | 196.00 shares | 0.94 | Common equity | Long | USA |
Sartorius AG | 36.12 k | 99.00 shares | 0.91 | Preferred equity | Long | Germany |
NUVL Nuvalent Inc - Ordinary Shares | 36.08 k | 480.00 shares | 0.91 | Common equity | Long | USA |
ELV Elevance Health Inc | 33.06 k | 67.00 shares | 0.83 | Common equity | Long | USA |
SYK Stryker Corp. | 31.20 k | 93.00 shares | 0.79 | Common equity | Long | USA |
PEN Penumbra Inc | 31.02 k | 123.00 shares | 0.78 | Common equity | Long | USA |
ABMD Abiomed Inc | 29.64 k | 131.00 shares | 0.75 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 29.50 k | 574.00 shares | 0.74 | Common equity | Long | USA |
Merus NV
|
29.44 k | 825.00 shares | 0.74 | Common equity | Long | Netherlands |
ABT Abbott Laboratories | 29.42 k | 260.00 shares | 0.74 | Common equity | Long | USA |
LH Laboratory Corp. Of America Holdings | 28.90 k | 130.00 shares | 0.73 | Common equity | Long | USA |
AVTR Avantor Inc. | 28.74 k | 1.25 k shares | 0.72 | Common equity | Long | USA |
SNY Sanofi | 28.44 k | 570.00 shares | 0.72 | Common equity | Long | France |
HOLX Hologic, Inc. | 28.29 k | 380.00 shares | 0.71 | Common equity | Long | USA |
CNC Centene Corp. | 28.17 k | 374.00 shares | 0.71 | Common equity | Long | USA |
INCY Incyte Corp. | 27.33 k | 465.00 shares | 0.69 | Common equity | Long | USA |
Alcon Inc
|
27.11 k | 361.00 shares | 0.68 | Common equity | Long | Switzerland |
GILD Gilead Sciences, Inc. | 26.84 k | 343.00 shares | 0.68 | Common equity | Long | USA |
UTHR United Therapeutics Corp | 26.42 k | 123.00 shares | 0.67 | Common equity | Long | USA |
BRKR Bruker Corp | 25.89 k | 362.00 shares | 0.65 | Common equity | Long | USA |
BeiGene Ltd
|
25.35 k | 171.00 shares | 0.64 | Common equity | Long | Cayman Islands |
ConvaTec Group PLC
|
24.77 k | 8.14 k shares | 0.62 | Common equity | Long | UK |
Lonza Group AG
|
24.45 k | 50.00 shares | 0.62 | Common equity | Long | Switzerland |
VRTX Vertex Pharmaceuticals, Inc. | 23.40 k | 54.00 shares | 0.59 | Common equity | Long | USA |
EXEL Exelixis Inc | 21.59 k | 992.00 shares | 0.54 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 21.20 k | 506.00 shares | 0.53 | Common equity | Long | USA |
CABA Cabaletta Bio Inc | 20.99 k | 1.03 k shares | 0.53 | Common equity | Long | USA |
PTGX Protagonist Therapeutics Inc | 20.23 k | 809.00 shares | 0.51 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 20.04 k | 481.00 shares | 0.50 | Common equity | Long | USA |
DXCM Dexcom Inc | 19.17 k | 158.00 shares | 0.48 | Common equity | Long | USA |
ARVN Arvinas Inc | 18.47 k | 445.00 shares | 0.47 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 18.21 k | 634.00 shares | 0.46 | Common equity | Long | USA |
CNMD Conmed Corp. | 17.88 k | 187.00 shares | 0.45 | Common equity | Long | USA |
Roivant Sciences Ltd
|
17.80 k | 1.78 k shares | 0.45 | Common equity | Long | Bermuda |
Genmab A/S
|
16.04 k | 58.00 shares | 0.40 | Common equity | Long | Denmark |
KRTX Karuna Therapeutics Inc | 13.79 k | 44.00 shares | 0.35 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 13.48 k | 309.00 shares | 0.34 | Common equity | Long | Cayman Islands |
SAGE Sage Therapeutics Inc | 13.46 k | 525.00 shares | 0.34 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 13.18 k | 238.00 shares | 0.33 | Common equity | Long | USA |
MLTX MoonLake Immunotherapeutics - Ordinary Shares | 12.68 k | 227.00 shares | 0.32 | Common equity | Long | Cayman Islands |
IMGN Immunogen, Inc. | 12.61 k | 430.00 shares | 0.32 | Common equity | Long | USA |
BIO Bio-Rad Laboratories Inc. - Ordinary Shares | 12.19 k | 38.00 shares | 0.31 | Common equity | Long | USA |
EHC Encompass Health Corp | 12.01 k | 169.00 shares | 0.30 | Common equity | Long | USA |
DYN Dyne Therapeutics Inc | 11.96 k | 559.00 shares | 0.30 | Common equity | Long | USA |
PTCT PTC Therapeutics Inc | 11.58 k | 444.00 shares | 0.29 | Common equity | Long | USA |
GLPG Galapagos NV | 11.12 k | 296.00 shares | 0.28 | Common equity | Long | Belgium |
EXAS Exact Sciences Corp. | 11.12 k | 170.00 shares | 0.28 | Common equity | Long | USA |
TCRX Tscan Therapeutics Inc | 10.96 k | 2.14 k shares | 0.28 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 10.93 k | 323.00 shares | 0.28 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 10.86 k | 450.00 shares | 0.27 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 10.50 k | 238.00 shares | 0.26 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 10.24 k | 369.00 shares | 0.26 | Common equity | Long | USA |
Nyxoah SA
|
10.24 k | 946.00 shares | 0.26 | Common equity | Long | Belgium |
Alkermes PLC
|
10.04 k | 371.00 shares | 0.25 | Common equity | Long | Ireland |
BCYC Bicycle Therapeutics Plc | 9.95 k | 570.00 shares | 0.25 | Common equity | Long | UK |
Arcturus Therapeutics Holdings, Inc. | 9.76 k | 296.00 shares | 0.25 | Common equity | Long | USA |
Biohaven Ltd
|
9.74 k | 219.00 shares | 0.25 | Common equity | Long | Virgin Islands (British) |
GH Guardant Health Inc | 8.53 k | 389.00 shares | 0.21 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 8.49 k | 262.00 shares | 0.21 | Common equity | Long | USA |
CGON Cg Oncology Inc. | 8.12 k | 218.00 shares | 0.20 | Common equity | Long | USA |
LUNG Pulmonx Corp | 8.09 k | 609.00 shares | 0.20 | Common equity | Long | USA |
SGMT Sagimet Biosciences Inc. | 8.01 k | 845.00 shares | 0.20 | Common equity | Long | USA |
GKOS Glaukos Corporation | 7.57 k | 85.00 shares | 0.19 | Common equity | Long | USA |
AXSM Axsome Therapeutics Inc | 6.75 k | 75.00 shares | 0.17 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 6.58 k | 104.00 shares | 0.17 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 6.54 k | 268.00 shares | 0.16 | Common equity | Long | USA |
BDTX Black Diamond Therapeutics Inc | 6.44 k | 1.68 k shares | 0.16 | Common equity | Long | USA |
SIBN SI-BONE Inc | 6.06 k | 300.00 shares | 0.15 | Common equity | Long | USA |
TNDM Tandem Diabetes Care Inc | 6.04 k | 265.00 shares | 0.15 | Common equity | Long | USA |
Immatics NV
|
6.03 k | 531.00 shares | 0.15 | Common equity | Long | Netherlands |
AUTL Autolus Therapeutics plc | 5.71 k | 949.00 shares | 0.14 | Common equity | Long | UK |
Novocure Ltd
|
5.36 k | 385.00 shares | 0.14 | Common equity | Long | Jersey |
BMEA Biomea Fusion Inc | 5.28 k | 292.00 shares | 0.13 | Common equity | Long | USA |
VYGR Voyager Therapeutics Inc | 5.22 k | 718.00 shares | 0.13 | Common equity | Long | USA |
Genmab A/S
|
5.22 k | 189.00 shares | 0.13 | Common equity | Long | Denmark |
MGNX Macrogenics Inc | 5.16 k | 361.00 shares | 0.13 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 5.14 k | 160.00 shares | 0.13 | Common equity | Long | USA |
RCUS Arcus Biosciences Inc | 5.03 k | 332.00 shares | 0.13 | Common equity | Long | USA |
AC Immune SA
|
4.94 k | 1.54 k shares | 0.12 | Common equity | Long | Switzerland |
MORF Morphic Holding Inc | 4.88 k | 154.00 shares | 0.12 | Common equity | Long | USA |
PRME Prime Medicine Inc | 4.64 k | 730.00 shares | 0.12 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 4.29 k | 125.00 shares | 0.11 | Common equity | Long | USA |
ATXS Astria Therapeutics Inc | 3.45 k | 265.00 shares | 0.09 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 3.17 k | 184.00 shares | 0.08 | Common equity | Long | USA |
MASS 908 Devices Inc | 3.17 k | 448.00 shares | 0.08 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics Inc | 2.47 k | 320.00 shares | 0.06 | Common equity | Long | USA |
CureVac NV
|
2.36 k | 656.00 shares | 0.06 | Common equity | Long | Netherlands |
Sophia Genetics SA
|
1.90 k | 413.00 shares | 0.05 | Common equity | Long | Switzerland |
LBPH Longboard Pharmaceuticals Inc | 1.23 k | 58.00 shares | 0.03 | Common equity | Long | USA |
GLUE Monte Rosa Therapeutics Inc | 1.22 k | 230.00 shares | 0.03 | Common equity | Long | USA |
TNYA Tenaya Therapeutics Inc | 1.03 k | 245.00 shares | 0.03 | Common equity | Long | USA |
KNTE Kinnate Biopharma Inc | 874.53 | 369.00 shares | 0.02 | Common equity | Long | USA |
CONTRA ABIOMED INC | 703.56 | 246.00 shares | 0.02 | Long | USA | |
CONTRA MIRATI THERAPEU | 233.80 | 334.00 shares | 0.01 | Long | USA | |
CONTRA FREQUENCY THERA | 5.71 | 420.00 shares | 0.00 | Long | USA | |
PURCHASED JPY / SOLD USD
Barclays Bank PLC
|
-392.21 | 1.00 contracts | -0.01 | DFE | N/A | Japan |
PURCHASED JPY / SOLD USD
Morgan Stanley & Co. International PLC
|
-2.11 k | 1.00 contracts | -0.05 | DFE | N/A | Japan |